Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Formic Acid
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : St. Joseph's Health Care London
Deal Size : Inapplicable
Deal Type : Inapplicable
Fecal Microbiota Translantation (FMT) to Reduce Inflammation in PLWH: The Gutsy Pilot Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 01, 2023
Lead Product(s) : Formic Acid
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : St. Joseph's Health Care London
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Formic Acid
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Fecal Microbiota Transplantation for Carbapenem Resistant Enterobacteriaceae
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 10, 2021
Lead Product(s) : Formic Acid
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Formic Acid
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 31, 2019
Lead Product(s) : Formic Acid
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Formic Acid
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase I/ Phase II
Sponsor : OpenBiome | Crohn's and Colitis Foundation | The Broad Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 25, 2016
Lead Product(s) : Formic Acid
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase I/ Phase II
Sponsor : OpenBiome | Crohn's and Colitis Foundation | The Broad Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Formic Acid
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 02, 2014
Lead Product(s) : Formic Acid
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable